15 April 2019
External Circular - . Patient Referral Policy
Reference: CIR-2019-00000175
|
15 April 2019
Code of Conduct for Healthcare Professionals Policy
Reference: CIR-2019-00000171
|
15 April 2019
Standing Child Protection Committee - DHA
Reference: CIR-2019-00000170
|
14 April 2019
Standing Child Protection Committee - DHA
Reference: CIR-2019-00000168
|
14 April 2019
Recall all batches & Suspend importation of Quinine Dihydrochloride 300mg/2ml inj
Reference: CIR-2019-00000164
|
14 April 2019
Suspend importation & recall of pharmaceutical product Phenylephrine 10mg
Reference: CIR-2019-00000163
|
14 April 2019
Removal of Suspension of registration import & marketing of Amoclan Suspension
Reference: CIR-2019-00000162
|
14 April 2019
Safety alert for the medical device Automatic Transport Ventilators
Reference: CIR-2019-00000161
|
14 April 2019
Warning from using herbal product X Power 3 Tablet
Reference: CIR-2019-00000160
|
14 April 2019
Warning from using herbal product Magnum XXL Capsule
Reference: CIR-2019-00000159
|
14 April 2019
Warning from using herbal product Lotus Flower Capsule
Reference: CIR-2019-00000158
|
14 April 2019
Alerts on the use of E- Cigarette
Reference: CIR-2019-00000157
|
14 April 2019
Safety update of a pharmaceutical product Benlysta (Belimumab)
Reference: CIR-2019-00000156
|
14 April 2019
Safety update of a pharmaceutical product Actemra / RoActemra (Tocikizumab)
Reference: CIR-2019-00000155
|
08 April 2019
Diversion of Disaster related work to Disaster Management Office
Reference: CIR-2019-00000152
|
08 April 2019
Diversion of Disaster related work to Disaster Management Office
Reference: CIR-2019-00000151
|
01 April 2019
Warning of using herbal product cause liver damage
Reference: CIR-2019-00000144
|
01 April 2019
Withdrawal two pharmaceutical product Gupisone Syrup Lot No: 0001 & 0002
Reference: CIR-2019-00000142
|
01 April 2019
Withdrawal one pharmaceutical product Flourouracil 500mg / 10ml Inj
Reference: CIR-2019-00000143
|
01 April 2019
Warning of using herbal product Shui An & Yang Xue Sheng Fa Capsule
Reference: CIR-2019-00000141
|
28 March 2019
Withdrawal two batch’s for the Pharmaceutical product Extraneal Peritoneal Dialysis
Reference: CIR-2019-00000135
|
26 March 2019
Withdrawal one batch from the Pharmaceutical product Sodium Bicarbonate 325mg
Reference: CIR-2019-00000134
|
26 March 2019
Withdrawal one batch from the medical device Transseptal Needle Lot No 8833687
Reference: CIR-2019-00000133
|
26 March 2019
Safety alerts for the medical products APO- Losartan & PMS-Losartan Tablet
Reference: CIR-2019-00000132
|
26 March 2019
Safety Alerts for the medical device enFlow fluid warming system disposable Cartridge
Reference: CIR-2019-00000131
|
26 March 2019
Safety alerts from using the Nutritional supplements Bluefusion Capsules
Reference: CIR-2019-00000130
|
21 March 2019
Withdrawal one batch of Pharmaceutical product Zypressin Injection (Vasopressin 20 IU)
Reference: CIR-2019-00000128
|
21 March 2019
Add a warning to pharmaceuticals containing the active substance Febuxostat
Reference: CIR-2019-00000127
|
21 March 2019
Adding warning for the pharmaceutical product containing the active ingredient of Tofacitinib
Reference: CIR-2019-00000126
|
20 March 2019
Safety alerts for medical devices
Reference: CIR-2019-00000108
|
20 March 2019
Safety alerts for medical device Zoll Life Vest 4000 Wearable Cardioverter
Reference: CIR-2019-00000107
|
20 March 2019
Safety Alerts for the medical device Terumo Needle & Terumo Needle Neolus
Reference: CIR-2019-00000106
|
20 March 2019
Safety alerts for pharmaceutical product Amlopress (Amlodipine) 5mg Capsules
Reference: CIR-2019-00000105
|
20 March 2019
Safety alerts for pharmaceutical product VEGGIE VITAMINE D3
Reference: CIR-2019-00000104
|
20 March 2019
Warning from using two batch’s from Talcum powder AJMAL SACRIFICE FOR HER
Reference: CIR-2019-00000103
|
20 March 2019
Safety alerts from using the Nutritional supplements Golean Detox Capsules
Reference: CIR-2019-00000102
|
20 March 2019
Safety alerts from using the Nutritional Supplement Black Horse
Reference: CIR-2019-00000101
|
20 March 2019
Prohibit dispensing cough products and colds that contain Opioid for children and youths
Reference: CIR-2019-00000125
|
20 March 2019
Withdrawal all batch’s and Suspend registration for pharmaceticeual product Clarex (Clarithromycin) 500mg tablet
Reference: CIR-2019-00000121
|
20 March 2019
Withdrawal all batch’s and Suspend registration for pharmaceticeual product Beresar(Irbesartan) 75, 150, 300MG tablet
Reference: CIR-2019-00000120
|
20 March 2019
Withdrawal all batch’s and suspend drug registration Simvaten (Simvastatin) 40mg tablet
Reference: CIR-2019-00000119
|
20 March 2019
Withdrawal all batch’s and suspend drug registration Omeprex (Omeprazole) 20mg tablet
Reference: CIR-2019-00000118
|
20 March 2019
Withdrawal all batch’s and suspend drug registration Hetlosar 50 &100 mg ( Losartan Potassium) Tablet
Reference: CIR-2019-00000117
|
20 March 2019
Withdrawal all batch’s and suspend drug registration Floxacin (Ciprofloxacin) 500mg Coated tablet
Reference: CIR-2019-00000116
|
20 March 2019
Withdrawal all batch’s and suspend drug registration Azomax ( Azithromycin) 250mg
Reference: CIR-2019-00000115
|
20 March 2019
Withdrawal all batch’s and suspend drug registration Arbitense 50 &100 mg ( Losartan Potassium) Tablet
Reference: CIR-2019-00000114
|
20 March 2019
Withdrawal all batch’s and suspend drug registration Amopress(Amlodipine) 5mg Capsule
Reference: CIR-2019-00000113
|
20 March 2019
Withdrawal two batch’s for nutritional supplement for BLEMIL PLUS HR 1 & 2 400 GR
Reference: CIR-2019-00000112
|
20 March 2019
Withdrawal two batch’s for the Pharmaceutical product Zargo 100mg (Losartan Potassium) tablet
Reference: CIR-2019-00000111
|
20 March 2019
Withradwal one batch for Sodium Bicarbonate 325 mg tablet
Reference: CIR-2019-00000110
|
20 March 2019
Withdrawal Pharmaceutical product CPRESSIN-P Injection (Vasopressin 20 IU)
Reference: CIR-2019-00000109
|
13 March 2019
Invitation to attend a training workshop for integration between HIS system and the unified electronic system for Narcotics, control, semi control platform
Reference: CIR-2019-00000100
|
12 March 2019
Awareness of Dubai Medical Journal (DMJ) Amongst DHA Licensees
Reference: CIR-2019-00000089
|
11 March 2019
Circular No. 16 Adding warnings to the pharmaceutical product Lemtrade (Alemtuzumab)
Reference: CIR-2019-00000045
|
11 March 2019
circular #17 Safety report while using a medical device to check blood sugar FreeStyle Libre Flash Gluensor
Reference: CIR-2019-00000051
|
11 March 2019
Policy for Brain Death Determination
Reference: CIR-2019-00000094
|
11 March 2019
Withdrawal & Suspended pharmaceutical product Sedofen Syrup
Reference: CIR-2019-00000098
|
11 March 2019
Safety alerts Accu-Chek Insight insulin pumps
Reference: CIR-2019-00000097
|
11 March 2019
Pharmaceutical safety of pharmaceuticals containing active substance Chlorhexidine
Reference: CIR-2019-00000096
|
10 March 2019
DHA RPEP-1: Basics of Radiation Protection in Hospitals (Radiology Practices)
Reference: CIR-2019-00000081
|
10 March 2019
Policy for Brain Death Determination
Reference: CIR-2019-00000079
|
28 February 2019
Withdrawal numbers of special batches for pharmaceutical product Cefuzime 500mg Tab & Cefuzime 250mg Tab
Reference: CIR-2019-00000074
|
28 February 2019
Withdrawal the batch no (0621) for the pharmaceutical product Profinal 100mg /5ml pediatric oral suspension 110ml
Reference: CIR-2019-00000073
|
28 February 2019
Safety alerts from using the Nutritional Supplement Nasti for Men capsules
Reference: CIR-2019-00000069
|
28 February 2019
Adding warnings to the pharmaceutical product Eloxatin 5mg/ml Concentrate solution for infusion ( Oxaliplayin)
Reference: CIR-2019-00000067
|
28 February 2019
Adding warning to the pharmaceutical product Tecentriq ( Atezolizumab)
Reference: CIR-2019-00000065
|
28 February 2019
Withdrawal medical device Ophthalmic implant Raindrop Near Vision Inlay
Reference: CIR-2019-00000076
|
28 February 2019
Withdrawal medical device Subset of Medtronic Dual Chamber Pacemaker
Reference: CIR-2019-00000075
|
28 February 2019
Safety alerts for the medical product Paclitaxel –Coated Balloons & Paclitaxel – Eluting Stents
Reference: CIR-2019-00000072
|
28 February 2019
Safety alerts for the medical product Clean line – Ultra-Sound Gel Sanitizer
Reference: CIR-2019-00000071
|
28 February 2019
Warning of using of breast implants and the possibility of accompanying them with cancer
Reference: CIR-2019-00000070
|
28 February 2019
Safety alerts from using the Nutritional Supplement Festal
Reference: CIR-2019-00000068
|
28 February 2019
Safety alerts from using the Nutritional Supplement Leopard Miracle Honey
Reference: CIR-2019-00000066
|
27 February 2019
Circular # 18 Withdrawal five batch’s from the Pharmaceutical Product (Amubaro)
Reference: CIR-2019-00000053
|
25 February 2019
Safety Alerts and Warnings of withdrawal pharmaceutical product for month of Jan 2019
Reference: CIR-2019-00000063
|
20 February 2019
Circular # 18 Withdrawal five batch’s from the Pharmaceutical Product (Amubaro)
Reference: CIR-2019-00000054
|
05 February 2019
circular # 12 - Withdrawal all batch’s for Zordyl Mouth Wash
Reference: CIR-2019-00000040
|
05 February 2019
Updated Features and processes in New Sheryan
Reference: CIR-2019-00000039
|
29 January 2019
Live Demonstration - Q & A session on the new System "Sheryan”
Reference: CIR-2019-00000035
|
29 January 2019
Live Demonstration - Q & A session on the new System "Sheryan”
Reference: CIR-2019-00000031
|
29 January 2019
Live Demonstration - Q & A session on the new System "Sheryan”
Reference: CIR-2019-00000030
|
28 January 2019
Updating on-Relocation of Offices and Services of Health Regulation Sector
Reference: CIR-2019-00000028
|
20 January 2019
Circular # 9 "Relocation of Offices and Services of Health Regulation Sector"
Reference: CIR-2019-00000003
|
20 January 2019
Circular # 9 "Relocation of Offices and Services of Health Regulation Sector"
Reference: CIR-2019-00000005
|
20 January 2019
Circular # 9 "Relocation of Offices and Services of Health Regulation Sector"
Reference: CIR-2019-00000002
|
17 January 2019
Dubai Health Forum 2019
Reference: CIR-2019-SHN0911
|
16 January 2019
Circular # 7 Withdrawal And Suspension Of Jusprin 81Mg Tablet
Reference: CIR-2019-SHN0910
|
08 January 2019
Circular #4 Temporary Outage Of The E- Licensing System “Sheryan”
Reference: CIR-2019-SHN0907
|
24 December 2018
[Reminder] Updated On Circular # 169 E-Survey For Information And Data Submission Of Select Measures In Dha Qeyas Project
Reference: CIR-2018-SHN0905
|
23 December 2018
[Reminder] Circular # 182 Pending Applications In The E-Licensing System "Sheryan"
Reference: CIR-2018-SHN0904
|
20 December 2018
[Reminder] Circular # 181 Warning To Withdrawal The Batch For Losartan Potassium
Reference: CIR-2018-SHN0903
|
20 December 2018
[Reminder] Circular 180 - Withdrawal Pharmaceutical Product Batch For Azimac 500
Reference: CIR-2018-SHN0902
|
20 December 2018
[Reminder] Circular # 179 Safety Reports Of Medical Devices Cardio Save Intra-Aortic Balloon Pump
Reference: CIR-2018-SHN0901
|
19 December 2018
[Reminder] Circular 178 Safety Alerts For Pharmaceutical Withdrawal Month On Oct2018
Reference: CIR-2018-SHN0900
|
19 December 2018
Circular # 174 Warning To Use The Blood Level Of The Warfarin Test Strips
Reference: CIR-2018-SHN0896
|
19 December 2018
[Reminder] Circular # 172 Safety Alerts And Warnings For The Month Of September 2018
Reference: CIR-2018-SHN0894
|
19 December 2018
[Reminder] Circular 171 Withdrawal Medical Device Fc 500 And The Epics Xl Series Flow Cytometers
Reference: CIR-2018-SHN0893
|
19 December 2018
[Reminder] Circular # 176 Warning To Use The Typhim Vi 0.5Ml Vaccine
Reference: CIR-2018-SHN0898
|
19 December 2018
[Reminder] Circular #175 Withdrawal Medical Product Containing The Active Ingredient Of Valsartan
Reference: CIR-2018-SHN0897
|
11 December 2018
[Reminder] Circular # 172 On Safety Report For Medical Device “Getting’S Maquet/Data Scope Intra – Aortic Balloons Pumps”
Reference: CIR-2018-SHN0888
|
11 December 2018
[Reminder] Circular # 171 Modification Of Dispensing Pharmaceutical Product (Buprenorphine )
Reference: CIR-2018-SHN0887
|
11 December 2018
[Reminder] Circular #174 On Withdrawal All Batches And Hold Registration For The Pharmaceutical Product Cefuzime 125Mg/5Ml Powder For Suspension
Reference: CIR-2018-SHN0890
|
11 December 2018
[Reminder] Circular # 173 Safety Report Regarding Pharmaceutical Product ““ Puriton Eye Relief Drops 0.5 Oz.”
Reference: CIR-2018-SHN0889
|
17 October 2018
[Reminder] Circular 167 A Week Without Service Centers - Initiative
Reference: CIR-2018-SHN0883
|
